190 related articles for article (PubMed ID: 15170578)
1. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.
Cairns NJ; Uryu K; Bigio EH; Mackenzie IR; Gearing M; Duyckaerts C; Yokoo H; Nakazato Y; Jaros E; Perry RH; Arnold SE; Lee VM; Trojanowski JQ
Acta Neuropathol; 2004 Sep; 108(3):213-23. PubMed ID: 15170578
[TBL] [Abstract][Full Text] [Related]
2. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.
Mosaheb S; Thorpe JR; Hashemzadeh-Bonehi L; Bigio EH; Gearing M; Cairns NJ
Acta Neuropathol; 2005 Oct; 110(4):360-8. PubMed ID: 16025283
[TBL] [Abstract][Full Text] [Related]
3. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study.
Yokota O; Tsuchiya K; Terada S; Ishizu H; Uchikado H; Ikeda M; Oyanagi K; Nakano I; Murayama S; Kuroda S; Akiyama H
Acta Neuropathol; 2008 May; 115(5):561-75. PubMed ID: 18080129
[TBL] [Abstract][Full Text] [Related]
4. alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.
Cairns NJ; Zhukareva V; Uryu K; Zhang B; Bigio E; Mackenzie IR; Gearing M; Duyckaerts C; Yokoo H; Nakazato Y; Jaros E; Perry RH; Lee VM; Trojanowski JQ
Am J Pathol; 2004 Jun; 164(6):2153-61. PubMed ID: 15161649
[TBL] [Abstract][Full Text] [Related]
5. Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.
Armstrong RA; Cairns NJ
J Neural Transm (Vienna); 2007; 114(4):451-6. PubMed ID: 17109074
[TBL] [Abstract][Full Text] [Related]
6. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.
Cairns NJ; Grossman M; Arnold SE; Burn DJ; Jaros E; Perry RH; Duyckaerts C; Stankoff B; Pillon B; Skullerud K; Cruz-Sanchez FF; Bigio EH; Mackenzie IR; Gearing M; Juncos JL; Glass JD; Yokoo H; Nakazato Y; Mosaheb S; Thorpe JR; Uryu K; Lee VM; Trojanowski JQ
Neurology; 2004 Oct; 63(8):1376-84. PubMed ID: 15505152
[TBL] [Abstract][Full Text] [Related]
7. FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.
Page T; Gitcho MA; Mosaheb S; Carter D; Chakraverty S; Perry RH; Bigio EH; Gearing M; Ferrer I; Goate AM; Cairns NJ; Thorpe JR
J Mol Neurosci; 2011 Nov; 45(3):409-21. PubMed ID: 21603978
[TBL] [Abstract][Full Text] [Related]
8. Topography of alpha-internexin-positive neuronal aggregates in 10 patients with neuronal intermediate filament inclusion disease.
Armstrong RA; Cairns NJ
Eur J Neurol; 2006 May; 13(5):528-32. PubMed ID: 16722980
[TBL] [Abstract][Full Text] [Related]
9. Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID): a study original using alpha-internexin immunohistochemistry.
Armstrong RA; Cairns NJ
Clin Neuropathol; 2006; 25(5):209-15. PubMed ID: 17007442
[TBL] [Abstract][Full Text] [Related]
10. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease.
Neumann M; Roeber S; Kretzschmar HA; Rademakers R; Baker M; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):605-16. PubMed ID: 19669651
[TBL] [Abstract][Full Text] [Related]
11. Screening for neurofilament inclusion disease using alpha-internexin immunohistochemistry.
Uchikado H; Shaw G; Wang DS; Dickson DW
Neurology; 2005 May; 64(9):1658-9. PubMed ID: 15883343
[No Abstract] [Full Text] [Related]
12. Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).
Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
J Neural Transm (Vienna); 2011 Nov; 118(11):1651-7. PubMed ID: 21792670
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration with features of NIFID and ALS--extended clinical and neuropathological spectrum.
Roeber S; Bäzner H; Hennerici M; Porstmann R; Kretzschmar HA
Brain Pathol; 2006 Jul; 16(3):228-34. PubMed ID: 16911480
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic variability within the inclusion body spectrum of basophilic inclusion body disease and neuronal intermediate filament inclusion disease in frontotemporal lobar degenerations with FUS-positive inclusions.
Gelpi E; Lladó A; Clarimón J; Rey MJ; Rivera RM; Ezquerra M; Antonell A; Navarro-Otano J; Ribalta T; Piñol-Ripoll G; Pérez A; Valldeoriola F; Ferrer I
J Neuropathol Exp Neurol; 2012 Sep; 71(9):795-805. PubMed ID: 22892522
[TBL] [Abstract][Full Text] [Related]
15. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.
Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
Acta Neuropathol; 2011 Feb; 121(2):219-28. PubMed ID: 20886222
[TBL] [Abstract][Full Text] [Related]
16. Basophilic inclusions and neuronal intermediate filament inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Ito H
Neuropathology; 2014 Dec; 34(6):589-95. PubMed ID: 24673472
[TBL] [Abstract][Full Text] [Related]
17. Extending the clinicopathological spectrum of neurofilament inclusion disease.
Josephs KA; Uchikado H; McComb RD; Bashir R; Wszolek Z; Swanson J; Matsumoto J; Shaw G; Dickson DW
Acta Neuropathol; 2005 Apr; 109(4):427-32. PubMed ID: 15754170
[TBL] [Abstract][Full Text] [Related]
18. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
Lashley T; Rohrer JD; Bandopadhyay R; Fry C; Ahmed Z; Isaacs AM; Brelstaff JH; Borroni B; Warren JD; Troakes C; King A; Al-Saraj S; Newcombe J; Quinn N; Ostergaard K; Schrøder HD; Bojsen-Møller M; Braendgaard H; Fox NC; Rossor MN; Lees AJ; Holton JL; Revesz T
Brain; 2011 Sep; 134(Pt 9):2548-64. PubMed ID: 21752791
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease.
Molina-Porcel L; Lladó A; Rey MJ; Molinuevo JL; Martinez-Lage M; Esteve FX; Ferrer I; Tolosa E; Blesa R
Arch Neurol; 2008 Feb; 65(2):272-5. PubMed ID: 18268200
[TBL] [Abstract][Full Text] [Related]
20. An autopsy case report of neuronal intermediate filament inclusion disease presenting with predominantly upper motor neuron features.
Murakami A; Nakamura M; Nakamura Y; Kaneko S; Yakushiji Y; Kusaka H
Neuropathology; 2021 Oct; 41(5):357-365. PubMed ID: 34309938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
